Fibrogen announces the sale of fibrogen china to astrazeneca for approximately $160 million

San francisco, feb. 20, 2025 (globe newswire) -- fibrogen, inc. (nasdaq: fgen) today announced the sale of its china subsidiary to astrazeneca for approximately $160 million.

FGEN Ratings Summary

FGEN Quant Ranking